Use a forward-looking approach and deep insights to design effective Preferred Drug Lists
to maximize drug rebates, lower overall pharmacy program spending, and provide the best
clinical value while improving patient outcomes and safety.
Gainwell Technologies is the leading provider of technology, services and solutions that are vital to the administration and operations of health and human services programs. Our mission is to empower clients through innovative technologies and solutions to deliver great health and human services outcomes. Our experienced team provides exemplary, unmatched guidance to drive value and growth for states through the implementation and management of a Preferred Drug List (PDL) and Preferred Diabetic Supply Program (PDSP).
As a leader in the Medicaid arena, Gainwell operates independently without conflicts of interest to administer programs with your best interests at the forefront. We do not own or operate a commercial health plan or administer a commercial line of business. We do not own or operate a mail order or specialty pharmacy division, nor do we derive revenue from the sales of pharmaceuticals, or from rebates negotiated on your behalf. We work singularly to administer your Preferred Drug List and supplemental rebate programs with your best interests and final decisions, remaining with you.